Authors: Schwartz, JI Agrawal, NGB Wong, PH Bachmann, KA Porras, AG Miller, JL Ebel, DL Sack, MR Holmes, GB Redfern, JS Gertz, BJ

Citation: Ji. Schwartz et al., Lack of pharmacokinetic interaction between rofecoxib and methotrexate in rheumatoid arthritis patients, J CLIN PHAR, 41(10), 2001, pp. 1120-1130

Authors: Prueksaritanont, T Vega, JM Rogers, JD Gagliano, K Greenberg, HE Gillen, L Brucker, MJ McLoughlin, D Wong, PH Waldman, SA

Citation: T. Prueksaritanont et al., Simvastatin does not affect CYP3A activity, quantified by the erythromycinbreath test and oral midazolam pharmacokinetics, in healthy male subjects, J CLIN PHAR, 40(11), 2000, pp. 1274-1279

Authors: Van Hecken, A Schwartz, JI Depre, M De Lepeleire, I Dallob, A Tanaka, W Wynants, K Buntinx, A Arnout, J Wong, PH Ebel, DL Gertz, BJ De Schepper, PJ

Citation: A. Van Hecken et al., Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers, J CLIN PHAR, 40(10), 2000, pp. 1109-1120

Authors: Van Hecken, A Depre, M Verbesselt, R Wynants, K De Lepeleire, I Arnout, J Wong, PH Freeman, A Holland, S Gertz, B De Schepper, PJ

Citation: A. Van Hecken et al., Effect of montelukast on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers, J CLIN PHAR, 39(5), 1999, pp. 495-500

Authors: Kakuta, K Tamai, H Wong, PH Kawahara, S Tanaka, Y

Citation: K. Kakuta et al., Quantitative analysis of sequence length distribution of 1,2 units in polybutadienes by ozonolysis-GPC method, MACROMOLEC, 32(19), 1999, pp. 5994-5997